
Shattuck Labs STTK
$ 7.25
2.26%
Annual report 2025
added 03-05-2026
Shattuck Labs P/S Ratio 2011-2026 | STTK
Annual P/S Ratio Shattuck Labs
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 349 | 44.5 | 225 | 292 | 11.9 | 190 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 349 | 11.9 | 185 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 9.32 | 1.19 % | $ 603 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.89 | 0.51 % | $ 6.54 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.48 | 1.26 % | $ 3.73 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Innoviva
INVA
|
3.95 | $ 23.09 | 0.17 % | $ 1.56 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
35.7 | $ 104.34 | 2.72 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Innate Pharma S.A.
IPHA
|
14.7 | $ 1.45 | -2.03 % | $ 235 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.95 | -1.34 % | $ 4.86 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.08 | 0.74 % | $ 436 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 22.96 | 2.64 % | $ 2.92 B | ||
|
Edesa Biotech
EDSA
|
158 | $ 15.11 | -4.97 % | $ 48.3 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.44 | 1.77 % | $ 383 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 0.76 | -0.42 % | $ 27.9 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Exelixis
EXEL
|
5.05 | $ 45.14 | 1.01 % | $ 12.3 B |